Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ALPE OTCMKTS:AVPI OTCMKTS:BRPMU OTCMKTS:ENZC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALPEalpha-En$0.00-66.7%$0.00$0.00▼$0.00N/A-0.271,575 shs5,000 shsAVPIAVP$0.00$0.00▼$0.00N/AN/AN/AN/ABRPMUB. Riley Principal 150 Merger$13.45+21.8%$13.45$8.00▼$17.33N/AN/A3,891 shs1,700 shsENZCEnzolytics$0.00-14.3%$0.00$0.00▼$0.00N/AN/A4.60 million shs5.78 million shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALPEalpha-En0.00%0.00%-60.00%-50.00%0.00%AVPIAVP0.00%0.00%0.00%0.00%0.00%BRPMUB. Riley Principal 150 Merger0.00%0.00%0.00%0.00%0.00%ENZCEnzolytics-14.29%-25.00%0.00%-25.00%-73.91%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALPEalpha-EnN/AN/AN/AN/AN/AN/AN/AN/AAVPIAVPN/AN/AN/AN/AN/AN/AN/AN/ABRPMUB. Riley Principal 150 MergerN/AN/AN/AN/AN/AN/AN/AN/AENZCEnzolyticsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALPEalpha-En 0.00N/AN/AN/AAVPIAVP 0.00N/AN/AN/ABRPMUB. Riley Principal 150 Merger 0.00N/AN/AN/AENZCEnzolytics 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALPEalpha-EnN/AN/AN/AN/AN/AN/AAVPIAVPN/AN/AN/AN/AN/AN/ABRPMUB. Riley Principal 150 MergerN/AN/AN/AN/AN/AN/AENZCEnzolyticsN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALPEalpha-EnN/AN/A0.00∞N/AN/AN/AN/AN/AAVPIAVPN/AN/A0.00N/AN/AN/AN/AN/AN/ABRPMUB. Riley Principal 150 MergerN/AN/A0.00∞N/AN/AN/AN/AN/AENZCEnzolyticsN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALPEalpha-EnN/AN/AN/AN/AN/AAVPIAVPN/AN/AN/AN/AN/ABRPMUB. Riley Principal 150 MergerN/AN/AN/AN/AN/AENZCEnzolyticsN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALPEalpha-EnN/AAVPIAVPN/ABRPMUB. Riley Principal 150 MergerN/AENZCEnzolyticsN/AInsider OwnershipCompanyInsider OwnershipALPEalpha-En57.70%AVPIAVP37.00%BRPMUB. Riley Principal 150 MergerN/AENZCEnzolyticsN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALPEalpha-En8N/AN/ANot OptionableAVPIAVP32N/AN/ANot OptionableBRPMUB. Riley Principal 150 Merger1N/AN/ANot OptionableENZCEnzolytics2N/AN/ANot OptionableENZC, ALPE, AVPI, and BRPMU HeadlinesRecent News About These CompaniesBulgarian Academy of Sciences Issues Report on Results of Its In Vivo Testing of IPF as an ImmunomodulatorSeptember 18, 2024 | accesswire.comADepartment of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences and Enzolytics, Inc. Execute Three Year AgreementSeptember 9, 2024 | accesswire.comAFinal Report From the National Centre of Infectious and Parasitic Diseases Concludes Lyophilized Pepsin Significantly Reduces the Survival and Proliferation of Growth in Specific Cancer CellsAugust 20, 2024 | accesswire.comAEnzolytics, Inc. and the Bulgarian Academy of Sciences Initiate a Cooperative Program Primarily Focusing on Applied and Strategic Research in Immunology for Cancer and HIV/AIDS ApplicationsJuly 31, 2024 | accesswire.comAEnzolytics, Inc. Enters Into Collaboration Agreement With Manufacturer Elimus Ltd.July 29, 2024 | accesswire.comAEnzolytics Inc. Supports Sagaliam Acquisition Corp Response to Competitors False and Misleading Press ReleaseJuly 26, 2024 | accesswire.comAEnzolytics, Inc. Enters Into Exclusive Worldwide License for Patented Immunotherapy Cancer TreatmentJuly 1, 2024 | accesswire.comAEnzolytics, Inc. Poised to Invest Alongside Sagaliam Acquisition Corp in Revolutionary Room Temperature SPAD TechnologyJune 3, 2024 | accesswire.comAEnzolytics, Inc. Announces Formation of Marketing Company in Partnership with Third Coast FulfillmentMay 2, 2024 | accesswire.comAEnzolytics Inc. Announces Dismissal of The Dimitar Savov Lawsuit in NevadaApril 23, 2024 | accesswire.comAEnzolytics, Inc. (ENZC)April 19, 2024 | finance.yahoo.comEnzolytics, Inc.: Update on Formulation of New Business StrategyApril 12, 2024 | finanznachrichten.deUpdate on Formulation of New Business StrategyApril 12, 2024 | accesswire.comAENZOLYTICS, INC. SHAREHOLDERS HOLD SPECIAL MEETING AND ELECT NEW BOARDMarch 25, 2024 | finance.yahoo.comEnzolytics Stock (OTC:ENZC) Insider TradesFebruary 26, 2024 | benzinga.comEnzolytics Stock (OTC:ENZC) Earnings Dates and Earning CallsFebruary 22, 2024 | benzinga.comEnzolytics, Inc. Announces Partnership With the Khalpey AI Lab To Forge the Future of Multi-Organ Remodeling and Rejuvenation With a Strategic Focus on LongevityJanuary 16, 2024 | finance.yahoo.comEnzolytics Inc ENZCNovember 11, 2023 | morningstar.comM"Exploring Penny Stocks: Four Watchlist Options" FTRS, ELTP, ENZC, ZOMOctober 31, 2023 | benzinga.comEnzolytics Announces the Signing of the Business Combination Agreement with Sagaliam Acquisition Corp (SAGA)September 18, 2023 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeENZC, ALPE, AVPI, and BRPMU Company Descriptionsalpha-En OTCMKTS:ALPE$0.0001 0.00 (-66.67%) As of 07/28/2025alpha-En Corporation, a development stage company, focuses on developing technologies for commercial manufacturing lithium metal for use in low-weight and high energy-density batteries; and compounds of lithium. The company was formerly known as Avenue Entertainment Group, Inc. and changed its name to alpha-En Corporation in July 2008. alpha-En Corporation was founded in 1969 and is based in Yonkers, New York.AVP OTCMKTS:AVPIAVP, Inc. produces, markets, and distributes volleyball events worldwide. The company was founded in 1983 and is based in Los Angeles, California.B. Riley Principal 150 Merger OTCMKTS:BRPMU$13.45 +2.41 (+21.83%) As of 07/19/2022B. Riley Principal 150 Merger Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York. B. Riley Principal 150 Merger Corp. is a subsidiary of B. Riley Financial, Inc.Enzolytics OTCMKTS:ENZC$0.0006 0.00 (-14.29%) As of 08/1/2025 03:29 PM EasternEnzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, the company's proprietary cell line produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics Inc. is based in Plano, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale Is PG&E an AI Power Play? Why Options Traders Are Betting Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
